Advancements in understanding the molecular mechanisms and clinical implications of Von Hippel-Lindau syndrome: A comprehensive review
Source: Translational Oncology
Pediatric patients with von Hippel–Lindau and hemangioblastomas treated successfully with belzutifan
Source: Pediatric Blood and Cancer
von Hippel-Lindau syndrome-related congenital polycythemia and response to belzutifan
Source: Haematologica
Current views on the role of HIF-2α in the pathogenesis and syndromic presentation of pheochromocytoma and paraganglioma
Source: Best Practice and Research: Clinical Endocrinology and Metabolism
The significant others of aurora kinase a in cancer: combination is the key
Source: Biomarker Research
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
